Scientists map the effects of 86 immune-signaling molecules called cytokines on every major immune cell type, creating a reference for studying the inner workings of the immune system.
Count Me In (CMI), an initiative focused on patient-partnered cancer research, has announced the launch of a new cohort for individuals with hepatocellular carcinoma (HCC) and HCC-like tumors.
By analyzing bacterial data, researchers have discovered thousands of rare new CRISPR systems that have a range of functions and could enable gene editing, diagnostics, and more.